News

Avantium spins out its pharmaceutical business

Today Avantium announced the spin out of its pharmaceutical service & development
business. The company has agreed to a management buy-out, to enable the business to
become fully independent, under the name Crystallics. The spin-out is part of
Avantium’s strategic plan to focus on its cleantech and chemicals activities.

Maccine & A*Star Initiate Preclinical Imaging Collaboration

Maccine Pte Ltd, the preclinical contract research organisation and the
Singapore Bioimaging Consortium (SBIC), a research consortium under the
Agency for Science, Technology and Research (A*STAR) today announced a
collaboration to establish a comprehensive preclinical imaging laboratory.

Inviragen and Duke-NUS Form Collaborative Vaccine Research and Development Program

Inviragen and Duke-NUS Form Collaborative Vaccine Research and Development
Program Fort Collins, CO and Singapore – January 26, 2011 – Inviragen, Inc. and the DukeNational University of Singapore Graduate Medical School (“Duke-NUS”) announced today that
they have completed a memorandum of understanding (MOU) to establish a partnership
between the two organizations

Smaato Raises $7M Venture Capital Round for International Expansion of Mobile Advertising Platform

Redwood Shores, CA / Singapore / Hamburg (www.smaato.com): January
26, 2011: Smaato (www.smaato.com), the leading mobile ad optimizer and mobile
advertising company, today announced the closing of a new institutional round of
funding. Singapore’s EDBI led the $7 million round, with participation from existing
shareholders including global private equity firm aeris CAPITAL. The new funds will
help fuel Smaato’s international expansion, in particular to extend its presence in
Asia from its Asian headquarters in Singapore.

TriReme Medical Announces Japanese Alliance

Pleasanton CA, Singapore, and Tokyo, January ___/PRNewswire/ — TriReme Medical, Inc. (TriReme)
today announced that it has signed an exclusive distribution and sales agreement for TriReme’s
complete line of advanced peripheral and coronary balloon dilatation catheters with Century Medical,
Inc. (CMI), a leading independent device distributor for the important Japanese market.

Cloudpic Global Inc. Series $6Million to build virtual studios in Asia via Singapore

SINGAPORE, Jan. 5, 2011 – To enable millions of new artists in Asia to be part of worldclass content productions, Gobi Partners, Inc., a leading digital media and technology
venture firm in Asia and Singapore’s EDB Investments Pte Ltd., invest US$6 Million in
Cloudpic® Global Inc., a pioneering leader in cloud computing applications for the digital
entertainment industry.

Norderstedt – 29 November 2010 – Triton Water AG (“Triton”) has announced that EDB Investments (“EDBI”) of Singapore is investing in Triton, the leading provider of complete water-cycle industrial and maritime water treatment solutions, backed by zouk ventures.

Norderstedt – 29 November 2010 – Triton Water AG (“Triton”) has announced that EDB
Investments (“EDBI”) of Singapore is investing in Triton, the leading provider of complete
water-cycle industrial and maritime water treatment solutions, backed by zouk ventures.

S*BIO’s JAK2 Inhibitor SB1518 Granted Orphan Drug Designation by European Commission for the Treatment of Myelofibrosis

Singapore, October 18, 2010 – S*BIO Pte Ltd today announced that the European Commission (EC)
has granted orphan drug designation to SB1518, its potent and orally active JAK2 inhibitor for the
treatment of primary myelofibrosis (PMF), post-polycythemia vera myelofibrosis (PPV-MF) and postessential thrombocythemia myelofibrosis (PET-MF). SB1518 has also received orphan drug designation
from the U.S. Food and Drug Administration (FDA) for the treatment of the same disorder